Related content

Correlation of p53 Immunostaining in Primary and Residual Ovarian Cancer at the Time of Positive Second-Look Laparotomy and its Prognostic Role: A Southwest Oncology Group Ancillary Study

By Hawes D.   Liu P.Y.   Muggia F.M.   Wilczynski S.   Cote R.   Felix J.   Terada K.   Belt R.J.   Alberts D.S.  

Gynecologic Oncology, Vol. 87, Iss. 1, 2002-10 ,pp. : 17-23

Academic Press

Access to resources Recommend Favorite

High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer

By Met Özcan   Balslev Eva   Flyger Henrik   Svane Inge  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 395-406

Springer Publishing Company

Access to resources Recommend Favorite

p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study

By Kai Kazuharu   Nishimura Reiki   Arima Nobuyuki   Miyayama Haruhiko   Iwase Hirotaka  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 426-433

Springer Publishing Company

Access to resources Recommend Favorite

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

By Iovino F.   Ferraraccio F.   Orditura M.   Antoniol G.   Morgillo F.   Cascone T.   Diadema M. R.   Aurilio G.   Santabarbara G.   Ruggiero R.   Belli C.   Irlandese E.   Fasano M.   Ciardiello F.   Procaccini E.   Schiavo F. Lo   Catalano G.   De Vita F.  

Cancer Investigation, Vol. 26, Iss. 3, 2008-02 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite

Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status

By Pratap R.   Shousha S.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 35-39

Springer Publishing Company

Access to resources Recommend Favorite